Privia Health Group, Inc. (PRVA)

In the past six months, Privia Health announced an agreement to acquire an ACO business from Evolent Health, Inc. for $100 million in cash, with a potential additional $13 million, expected to close in Q4 2025. The company reported its Q3 2025 earnings with revenue of $580.42 million, surpassing forecasts, and practice collections growing 27.1% year-over-year. RBC Capital initiated coverage with an Outperform rating and a $31.00 price target, and Citizens reiterated its Market Outperform rating and $31.00 price target. The stock experienced a slight decline of -2.74% over 10 trading days leading up to January 9, 2026, and fell by -0.475% on January 9, 2026, but increased by 12.34% over the last 12 months.

While specific details on demand seasonality are not extensively outlined, Privia Health expects to receive a significant portion of its shared savings cash payments in the second half of the year. Management expects similar seasonality in the second half of the year compared to the first half. The underlying demand for its physician enablement services appears relatively consistent, with revenue growth driven by network expansion and performance in value-based contracts.

Privia Health Group, Inc. is a physician-enablement company in the healthcare sector, focusing on Health Information Services and Healthcare Providers and Services. It provides a cloud-based technology platform and practice management services to help independent medical groups transition to value-based care models, while also supporting fee-for-service arrangements. The company's offerings include technology and population health tools, management services organizations, a single-TIN medical group, and accountable care organizations (ACOs). Privia Health also offers a network connecting providers with new patient populations and facilitating custom contracts.

Privia Health Group, Inc. has a national presence across 15 states and the District of Columbia, including Virginia, Maryland, the District of Columbia, Texas, Tennessee, Florida, and Georgia. In 2025, Privia Health expanded into Arizona. Other states include California, Connecticut, Delaware, Montana, North Carolina, and Ohio. As of late 2025, the company's network included over 5,250 implemented providers, caring for more than 5.6 million patients.

Privia Health Group, Inc. maintains a strong brand reputation, supported by positive analyst sentiment and robust financial performance. The company has a consensus rating of "Moderate Buy" from analysts, with a potential upside of approximately 30.2% from its current price. Privia Health scored higher than 96% of companies evaluated by MarketBeat, ranking 40th out of 916 stocks in the medical sector. The company's strong financial trajectory, including a 32.5% revenue increase in the latest quarter and a 94.1% jump in net income attributable to stockholders, underscores its operational efficiency and market strategy.

Privia Health Group, Inc. has an ownership structure heavily weighted towards institutional investors and company insiders. Institutional shareholders hold approximately 83.07% to 97.32% of the company's stock. Major institutional owners include BlackRock, Inc., Fmr Llc, Vanguard Group Inc, Durable Capital Partners LP, iShares Core S&P Small-Cap ETF, Rubicon Founders LLC, Riverbridge Partners Llc, State Street Corp, Van Berkom & Associates Inc., and Vanguard Total Stock Market Index Fund Investor Shares. Company insiders own approximately 1.92% to 10.70% of the stock. Pamplona Capital Management LLC is the largest individual shareholder, owning 95.88 million shares, representing 77.95% of the company.